Valence ロゴ
人気
ログイン
Loading data for RVTY — first visit, this takes a few seconds.

ウォッチリストに追加

Revvity Inc.

NYSE: RVTY · リアルタイム株価 · USD
124.13
+4.68 (3.92%)
終値時点： Aug 20, 2026, 8:00 PM
124.13
+0.00%
時間外: 5:10 PM

Revvity Inc. (RVTY) Stock Price, Analysis & Data

3.92%

データがありません

買気配121
時価総額13.85B
売上高（TTM）2.91B
純利益（TTM）237.37M
ベータ1.07
EPS（TTM）2.08
PER（TTM）59.68
予想PER21.07
PBR（TTM）1.92
PSR（TTM）4.76
Earnings DateOct 26, 2026
売気配133.58
出来高2,344,486
平均出来高（20日）1,492,922
始値118.26
前日終値119.45
当日レンジ116.95 - 124.42
52週レンジ81.22 - 124.42
アナリストn/a
目標株価n/a
配当$0.28 (0.23%)
権利落ち日2026年10月23日

RVTYについて

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its p...

[続きを読む]
業種 Diagnostics & Research
セクター Healthcare
IPO日 Feb 21, 1973
従業員数 11,000
上場取引所 NYSE
ティッカー RVTY
ウェブサイト https://www.revvity.com
企業情報の全文

業績

2025年のRevvityの売上高は2.86Bで、前年の2.76Bから3.67%の増加でした。 利益は241.2Mで、-10.79%の減少でした。

財務諸表

決算サプライズ

RevvityはAug 4, 2026に四半期決算を発表しました：
  • 売上高は n/a で、予想を下回りました $0, うち -100.00% の前年比減少.
  • EPSは 1.41 で、予想を上回りました 0.19, うち 19.49% の前年比増加にあたります.

    • 次回決算発表

    Revvity Inc.の決算発表予定日は Oct 26, 2026, 寄り付き前の予定です。
    アナリストの売上高予想は ... アップグレード
    news image

    1週間前 · Zacks

    Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs

    RVTY launches SuperFlex, a compact automated prenatal screening system aimed at expanding rapid in-house testing for smaller labs and clinics.

    news image

    1週間前 · StockStory

    The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call

    Revvity’s second quarter demonstrated year-over-year growth in both revenue and non-GAAP earnings, yet the market responded negatively, likely reflecting concerns about underlying segment dynamics and...

    news image

    1週間前 · Motley Fool

    Revvity (RVTY) Q2 2026 Earnings Call Transcript

    Diagnostics surged 11% organically as AI-driven demand accelerated.

    news image

    1週間前 · StockStory

    1 Profitable Stock on Our Buy List and 2 We Find Risky

    While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my...

    news image

    1週間前 · MarketBeat

    Revvity Q2 Earnings Call Highlights

    Revvity (NYSE:RVTY) reported second-quarter results above its expectations and raised its full-year outlook, citing continued strength in diagnostics, improving demand from pharmaceutical and biotechn...

    2ページ中1ページ